- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.01. | AbbVie and Simcere Zaiming link to develop trispecific antibody | ||
| 15.01. | JP Morgan 2025: Incyte expects period of 'defining catalysts' | ||
| 15.01. | Bringing Engineering to a New Level: ZETA's Integrated Approach | ||
| 15.01. | WHO reports eight deaths from suspected Marburg outbreak in Tanzania | ||
| 15.01. | JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m | ||
| 15.01. | Acadia submits MAA to EMA for Rett syndrome therapy | ||
| 15.01. | How a Fresh Approach to Supply Chains Can Unlock Scaling in Personalized Medicine | ||
| 15.01. | Aggressive protection of Stelara may indicate J&J's immunology strategy | ||
| 15.01. | Umoja secures $100m to advance CAR-T cell therapy pipeline | ||
| 15.01. | JP Morgan 2025: Thermo Fisher rides momentum to project strong growth in 2025 | ||
| 15.01. | JP Morgan 2025: Almirall updates strategy with focus on medical dermatology | ||
| 14.01. | JP Morgan 2025: Novartis streamlines its portfolio to drive future growth | ||
| 14.01. | Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m | ||
| 14.01. | JP Morgan 2025: Moderna stock suffers after CEO reveals conservative 2025 guidance | ||
| 14.01. | Clinical research survey results: The key pressures for SMEs and business outlook | ||
| 14.01. | J&J to leverage Intra-Cellular Therapies' neurology portfolio | ||
| 14.01. | Pharma to raise prices on more than 250 drugs in the US from January 2025 | ||
| 14.01. | Eisai and Biogen's subcutaneous Leqembi set for FDA review | ||
| 14.01. | Normunity raises $75m to advance solid tumour targeting T-cell engagers | ||
| 14.01. | JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen's obesity entrance | ||
| 14.01. | Enhancing patient engagement and outcomes in the NHS | ||
| 14.01. | Pharmaceutical Technology Excellence Awards 2024: Image Analysis Group | ||
| 14.01. | Pharmaceutical Technology Excellence Awards 2024: IFF Pharma Solutions | ||
| 14.01. | Pharmaceutical Technology Excellence Awards 2024: Syngene | ||
| 13.01. | Biogen proposes acquisition of partner Sage Therapeutics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
